Page last updated: 2024-12-05

4-ethyl-1-phospha-2,6,7 trioxabicyclo(2.2.2)octane-1-oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID13869
SCHEMBL ID813272
MeSH IDM0180153

Synonyms (56)

Synonym
4-aethyl-1-phospha-2,6,7-trioxabicyclo(2.2.2)octan-1-oxid
2,6,7-trioxa-1-phosphabicyclo-(2.2.2)octane, 4-ethyl-, 1-oxide
nsc 72890
2,6,7-trioxa-1-phosphabicyclo-[2.2.2]octane, 4-ethyl-, 1-oxide
4-ethyl-2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane 1-oxide
2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane, 4-ethyl-, 1-oxide
1005-93-2
nsc-72890
1, 2-ethyl-2-(hydroxymethyl)-, cyclic phosphate
trimethylolpropane phosphate
nsc72890
2,7-trioxa-1-phosphabicyclo[2.2.2]octane, 4-ethyl-, 1-oxide
wln: t4ptj ao bq c2q c1 dq
1, 2-ethyl-2-(hydroxymethyl)-, cyclic phosphate (1:1)
2-ethyl-2-(hydroxymethyl)-1,3-propanediol cyclic phosphate (1:1)
4-ethyl-1-phospha-2,7-trioxabicyclo[2.2.2]octane 1-oxide
4-aethyl-1-phospha-2,7-trioxabicyclo[2.2.2]octan 1-oxid
4-ethyl-2,7-trioxa-1-phosphabicyclo[2.2.2]octane 1-oxide
einecs 213-740-6
trimethylopropane phosphate
trimethyolpropane phosphate
2-ethyl-2-(hydroxymethyl)-1,3-propanediol, cyclic phosphate (1:1)
2,6,7-trioxa-1-phosphabicyclo(2.2.2)octane, 4-ethyl-, 1-oxide
4-ethyl-1-phospha-2,6,7 trioxabicyclo(2.2.2)octane-1-oxide
4-ethyl-2,6,7-trioxa-1-phosphabicyclo(2.2.2)octane 1-oxide
tmp-p
1-ethyl-1-phospha-2,6,7-trioxabicyclo(2.2.2)octane-1-oxide
4-ethyl-1-phospha-2,6,7-trioxabicyclo(2.2.2.)octane-1-oxide
1-ethyl-1-phospha-2,6,7-trioxabicyclo(2.2.2)octane 1-oxide
2-(hydroxymethyl)-2-ethyl-1,3-propanediol, cyclic phosphate (1:1)
4-ethyl-1-phospha-2,6,7-trioxabicyclo(2.2.2)octane-1-oxide
1,3-propanediol, 2-ethyl-2-(hydroxymethyl)-, cyclic phosphate
brn 1909748
4-aethyl-1-phospha-2,6,7-trioxabicyclo(2.2.2)octan-1-oxid [german]
4-ethyl-2,6,7-trioxa-1-phosphabicyclo(2.2.2)octane-1-oxide
ethyl bicyclic phosphate
etbicyphat
AKOS006272342
FT-0626165
1,1,1-trimethylolpropane phosphate
SCHEMBL813272
BYEFHDZWRALTEN-UHFFFAOYSA-N
DTXSID5058270
mfcd00043597
J-000170
4-ethyl-2,6,7-trioxa-1-phosphabicy-clo[2.2.2]octane 1-oxide
etbicyphat, >=95% (nmr), solid
4-ethyl-2,6,7-trioxa-1lambda5-phosphabicyclo[2.2.2]octane 1-oxide
4-ethyl-2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane-1-oxide
4-ethyl-2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane 1-oxide.
F82933
HY-139145
STARBLD0009575
BAA00593
trimethylolpropane (1,3,5-13c3) phosphate
4-ethyl-2,6,7-trioxa-1|e?-phosphabicyclo[2.2.2]octan-1-one

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" They showed no toxic cumulative effects."( Acute toxicity of bicyclic phosphorus esters.
Eben, A; Gröning, P; Kimmerle, G; Thyssen, J, 1976
)
0.26

Dosage Studied

ExcerptRelevanceReference
" Parallel dose-response curves suggest that TMPP acts by a competitive antagonism of GABA inhibition, and are consistent with reported patch-clamp analysis of TMPP-induced reduction of inhibitory postsynaptic current amplitudes."( Characterization of acute neurotoxic effects of trimethylolpropane phosphate via neuronal network biosensors.
Gramowski, A; Gross, GW; Keefer, EW; Pancrazio, JJ; Stenger, DA, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.26)18.7374
1990's8 (42.11)18.2507
2000's8 (42.11)29.6817
2010's2 (10.53)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index5.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]